Current treatment for visceral leishmaniasis (VL), compromised by drug resistance, toxicity, and extreme worth, requires for less complicated, safer, and low-cost medication. Artemisinin has been found to be an effectual drug varied in experimental fashions of leishmaniasis. Comparative genome and transcriptome analysis of in vitro-adapted artesunate-resistant and -sensitive wild-type Leishmania donovani parasites was carried out using next-generation sequencing and single-color DNA microarray know-how, respectively, to determine genes and interlinked pathways contributing to drug resistance. Full-genome sequence and, 237 insertion deletions, 616 copy amount variations (CNVs) (377 deletions and 239 duplications), and trisomy of chromosome 12 in Okay133AS-R parasites. Transcriptome analysis revealed differential expression of 208 genes (fold change ≥ 2) in Okay133AS-R parasites.
Purposeful categorization and analysis of modulated genes of interlinked pathways recognized plausible permutations in Okay133AS-R parasites, paying homage to (i) a dependency on lipid and amino acid metabolism for producing energy, (ii) diminished DNA and protein synthesis leading to parasites throughout the quiescence state, and (iii) vigorous drug efflux. The upregulated expression of cathepsin-L like protease, amastin-like ground protein, and amino acid transporter and downregulated expression of the gene encoding ABCG2, pteridine receptor, adenylatecyclase-type receptor, phosphoaceylglucosamine mutase, and positive hypothetical proteins are concordant with genomic alterations suggesting their potential place in drug resistance. The look at equipped an understanding of the molecular basis linked to artemisinin resistance in Leishmania parasites, which will be advantageous for safeguarding this drug for future use.
Polyvinyl alcohol-based electrospun matrix as a provide system for nanoemulsion containing chalcone in direction of Leishmania (Leishmania) amazonensis
Cutaneous leishmaniasis is a worldwide public nicely being draw back. Typical therapies, together with the extreme worth, have many hostile outcomes and circumstances of parasite’s resistance. Chalcones are secondary metabolites precursors throughout the flavonoid pathway and is perhaps obtained naturally, nevertheless with low yield from plant raw supplies. Thus, the utilization of synthetic chalcones has been a promising approach for the occasion of molecules with leishmanicidal train.
Thus, this work aimed to develop a managed launch system of two synthetic chalcone (trans-chalcones and three’-(trifluormethyl)-chalcone) using polyvinyl alcohol nanofibers (PVA) as scaffold. The affiliation of chalcones to the nanofibers was made by nanoemulsions (NE) thereof, i.e., a colloidal system on a nanometric scale, which allows compounds with reverse polarities to remain miscible and regular all by their manipulation. Chalcone nanoemulsions had been developed using the spontaneous emulsification method. The NE had been characterised referring to their particle measurement, polydispersion index (PDI), and zeta potential.
The outcomes confirmed NE with spherical kind, absolute values of zeta potential had been larger than 30 mV and homogeneous distribution pattern (PDI < 0.3). Dynamics mild scattering (DLS) analysis confirmed comparable hydrodynamic rays, i.e., 180 nm (trans-chalcone NE) and 178 nm (NE containing 3′-(trifluormethyl)-chalcone, together with presenting encapsulation effectivity values close to 100 %. Subsequently, the NE had been added to a polymeric reply of polyvinyl alcohol (PVA) and processed by the electrospinning method affording a PVA matrix (15 %, w/v) nanofiber containing the chalcones NE at 1 mg.mL-1. In a follow-up experiment, the pores and pores and skin permeation assay of the PVA matrix-chalcone NE was carried out in vitro using Franz kind diffusion cells and porcine ear as natural model of look at.
Capsid building of Leishmania RNA virus 1
Leishmania parasites set off a variety of indicators, along with mucocutaneous leishmaniasis, which results in the destruction of the mucous membranes of the nostril, mouth, and throat. The species of Leishmania carrying Leishmania RNA virus 1 (LRV1), from the family Totiviridae, normally are likely to set off excessive sickness and are a lot much less delicate to treatment than these that do not embrace the virus. Although the importance of LRV1 for the severity of leishmaniasis was discovered a really very long time prior to now, the development of the virus remained unknown. Proper right here, we present a cryo-electron microscopy reconstruction of the virus-like particle of LRV1 determined to a call of three.65 Å.
The capsid has icosahedral symmetry and is formed by 120 copies of a capsid protein assembled in uneven dimers. RNA genomes of viruses from the family Totiviridae are synthetized, nevertheless not capped on the 5′ end, by virus RNA-polymerases. To protect viral RNAs from degradation, capsid proteins of totivirus L-A cleave the 5′ caps of host mRNAs, creating decoys to overload the cellular RNA top quality administration system. Capsid proteins of LRV1 kind positively charged clefts, which stands out because the cleavage web sites for the 5′ cap of Leishmania mRNAs. Capsid proteins of LRV1 embrace a putative RNA binding web site distinct from that of the related L-A virus. The development of the LRV1 capsid permits the rational design of compounds concentrating on the putative de-capping web site. Such inhibitors is also developed proper right into a treatment for mucocutaneous leishmaniasis introduced on by LRV1-positive species of Leishmania
 Leishmania infantum IgG ELISA |
|||
| MBS494629-5x96Tests | MyBiosource | 5x96Tests | EUR 3180 |
|
Leishmania infantum IgG ELISA |
|||
| MBS494629-96Tests | MyBiosource | 96Tests | EUR 695 |
 Leishmania infantum |
|||
| Oneq-VH10-OneqVH100100D | Bioingentech | Oneq-VH100-100D | EUR 515 |
|
Leishmania infantum |
|||
| Oneq-VH10-OneqVH100150D | Bioingentech | Oneq-VH100-150D | EUR 594 |
|
Leishmania infantum |
|||
| Oneq-VH10-OneqVH10050D | Bioingentech | Oneq-VH100-50D | EUR 413 |
|
Leishmania infantum |
|||
| PCR-VH100-PCRVH10048D | Bioingentech | PCR-VH100-48D | EUR 230 |
|
Leishmania infantum |
|||
| PCR-VH100-PCRVH10096D | Bioingentech | PCR-VH100-96D | EUR 312 |
 Leishmania infantum PCR kit |
|||
| PCR-VH100-48D | Bioingentech | 50T | EUR 543.6 |
|
Leishmania infantum PCR kit |
|||
| PCR-VH100-96D | Bioingentech | 100T | EUR 686.4 |
 Leishmania infantum RT PCR kit |
|||
| RTq-VH100-100D | Bioingentech | 100T | EUR 860.4 |
|
Leishmania infantum RT PCR kit |
|||
| RTq-VH100-150D | Bioingentech | 150T | EUR 969.6 |
|
Leishmania infantum RT PCR kit |
|||
| RTq-VH100-50D | Bioingentech | 50T | EUR 717.6 |
 Leishmania infantum One-Step PCR kit |
|||
| Oneq-VH100-100D | Bioingentech | 100T | EUR 1039.2 |
|
Leishmania infantum One-Step PCR kit |
|||
| Oneq-VH100-150D | Bioingentech | 150T | EUR 1177.2 |
|
Leishmania infantum One-Step PCR kit |
|||
| Oneq-VH100-50D | Bioingentech | 50T | EUR 861.6 |
 Recombinant Leishmania infantum Histone H3 |
|||
| MBS1215897-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1050 |
|
Recombinant Leishmania infantum Histone H3 |
|||
| MBS1215897-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 630 |
|
Recombinant Leishmania infantum Histone H3 |
|||
| MBS1215897-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 805 |
|
Recombinant Leishmania infantum Histone H3 |
|||
| MBS1215897-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 735 |
|
Recombinant Leishmania infantum Histone H3 |
|||
| MBS1215897-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 940 |
 Recombinant Leishmania infantum Histone H2A.2 |
|||
| MBS1140804-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1055 |
|
Recombinant Leishmania infantum Histone H2A.2 |
|||
| MBS1140804-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 635 |
|
Recombinant Leishmania infantum Histone H2A.2 |
|||
| MBS1140804-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 805 |
|
Recombinant Leishmania infantum Histone H2A.2 |
|||
| MBS1140804-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 740 |
|
Recombinant Leishmania infantum Histone H2A.2 |
|||
| MBS1140804-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 945 |
 Recombinant Leishmania infantum Histone H2A.1 |
|||
| MBS1090044-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1055 |
|
Recombinant Leishmania infantum Histone H2A.1 |
|||
| MBS1090044-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 635 |
|
Recombinant Leishmania infantum Histone H2A.1 |
|||
| MBS1090044-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 805 |
|
Recombinant Leishmania infantum Histone H2A.1 |
|||
| MBS1090044-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 740 |
|
Recombinant Leishmania infantum Histone H2A.1 |
|||
| MBS1090044-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 945 |
 ViPrimePLUS Leishmania infantum qPCR Kit, 150rxns |
|||
| QM4007 | Vivantis | each | Ask for price |
 Recombinant antigen K39 for Leishmania infantum |
|||
| MBS505114-1mg | MyBiosource | 1mg | EUR 1265 |
|
Recombinant antigen K39 for Leishmania infantum |
|||
| MBS505114-5x1mg | MyBiosource | 5x1mg | EUR 5400 |
) Recombinant Leishmania Infantum FEN1 Protein (aa 1-395) |
|||
| VAng-Wyb7444-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5652 |
|
Description: Leishmania Infantum Flap endonuclease 1, recombinant protein. |
|||
|
Recombinant Leishmania Infantum FEN1 Protein (aa 1-395) |
|||
| VAng-Wyb7444-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 4002 |
|
Description: Leishmania Infantum Flap endonuclease 1, recombinant protein. |
|||
|
Recombinant Leishmania Infantum FEN1 Protein (aa 1-395) |
|||
| VAng-Wyb7444-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2733.6 |
|
Description: Leishmania Infantum Flap endonuclease 1, recombinant protein. |
|||
) Recombinant Leishmania Infantum ISP1 Protein (aa 1-146) |
|||
| VAng-Wyb7449-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3754.8 |
|
Description: Leishmania Infantum Ecotin-like protein 1, recombinant protein. |
|||
|
Recombinant Leishmania Infantum ISP1 Protein (aa 1-146) |
|||
| VAng-Wyb7449-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2683.2 |
|
Description: Leishmania Infantum Ecotin-like protein 1, recombinant protein. |
|||
|
Recombinant Leishmania Infantum ISP1 Protein (aa 1-146) |
|||
| VAng-Wyb7449-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1858.8 |
|
Description: Leishmania Infantum Ecotin-like protein 1, recombinant protein. |
|||
) Recombinant Leishmania Infantum JBP1 Protein (aa 1-814) |
|||
| VAng-Wyb7450-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Leishmania Infantum Thymine dioxygenase JBP1, partial, recombinant protein. |
|||
) Recombinant Leishmania Infantum JBP2 Protein (aa 1-1022) |
|||
| VAng-Wyb7451-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Leishmania Infantum Bifunctional helicase and thymine dioxygenase JBP2, partial, recombinant protein. |
|||
) Recombinant Leishmania Infantum LINJ_05_0060 Protein (aa 1-833) |
|||
| VAng-Wyb7455-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Leishmania Infantum Major vault protein, partial, recombinant protein. |
|||
) Recombinant Leishmania Infantum LINJ_14_1270 Protein (aa 1-560) |
|||
| VAng-Wyb7456-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Leishmania Infantum Bifunctional NAD (P) H-hydrate repair enzyme, partial, recombinant protein. |
|||
) Recombinant Leishmania Infantum LINJ_16_0320 Protein (aa 1-689) |
|||
| VAng-Wyb7457-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Leishmania Infantum tRNA (guanine (37)-N1)-methyltransferase, partial, recombinant protein. |
|||
) Recombinant Leishmania Infantum LINJ_20_0980 Protein (aa 1-344) |
|||
| VAng-Wyb7458-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5256 |
|
Description: Leishmania Infantum 1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LINJ_20_0980 Protein (aa 1-344) |
|||
| VAng-Wyb7458-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3723.6 |
|
Description: Leishmania Infantum 1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LINJ_20_0980 Protein (aa 1-344) |
|||
| VAng-Wyb7458-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2551.2 |
|
Description: Leishmania Infantum 1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase, recombinant protein. |
|||
) Recombinant Leishmania Infantum METK Protein (aa 1-392) |
|||
| VAng-Wyb7482-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5619.6 |
|
Description: Leishmania Infantum S-adenosylmethionine synthase, recombinant protein. |
|||
|
Recombinant Leishmania Infantum METK Protein (aa 1-392) |
|||
| VAng-Wyb7482-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3606 |
|
Description: Leishmania Infantum S-adenosylmethionine synthase, recombinant protein. |
|||
|
Recombinant Leishmania Infantum METK Protein (aa 1-392) |
|||
| VAng-Wyb7482-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2716.8 |
|
Description: Leishmania Infantum S-adenosylmethionine synthase, recombinant protein. |
|||
) Recombinant Leishmania Infantum RPS6 Protein (aa 1-249) |
|||
| VAng-Wyb7485-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4546.8 |
|
Description: Leishmania Infantum 40S ribosomal protein S6, recombinant protein. |
|||
|
Recombinant Leishmania Infantum RPS6 Protein (aa 1-249) |
|||
| VAng-Wyb7485-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3244.8 |
|
Description: Leishmania Infantum 40S ribosomal protein S6, recombinant protein. |
|||
|
Recombinant Leishmania Infantum RPS6 Protein (aa 1-249) |
|||
| VAng-Wyb7485-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2205.6 |
|
Description: Leishmania Infantum 40S ribosomal protein S6, recombinant protein. |
|||
) Recombinant Leishmania Infantum RPL37 Protein (aa 2-83) |
|||
| VAng-Wyb7483-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3294 |
|
Description: Leishmania Infantum 60S ribosomal protein L37, recombinant protein. |
|||
|
Recombinant Leishmania Infantum RPL37 Protein (aa 2-83) |
|||
| VAng-Wyb7483-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2353.2 |
|
Description: Leishmania Infantum 60S ribosomal protein L37, recombinant protein. |
|||
|
Recombinant Leishmania Infantum RPL37 Protein (aa 2-83) |
|||
| VAng-Wyb7483-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1627.2 |
|
Description: Leishmania Infantum 60S ribosomal protein L37, recombinant protein. |
|||
) Recombinant Leishmania Infantum RPS25 Protein (aa 1-120) |
|||
| VAng-Wyb7484-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3556.8 |
|
Description: Leishmania Infantum 40S ribosomal protein S25, recombinant protein. |
|||
|
Recombinant Leishmania Infantum RPS25 Protein (aa 1-120) |
|||
| VAng-Wyb7484-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2551.2 |
|
Description: Leishmania Infantum 40S ribosomal protein S25, recombinant protein. |
|||
|
Recombinant Leishmania Infantum RPS25 Protein (aa 1-120) |
|||
| VAng-Wyb7484-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1759.2 |
|
Description: Leishmania Infantum 40S ribosomal protein S25, recombinant protein. |
|||
) Recombinant Leishmania Infantum LinJ01.0780 Protein (aa 1-403) |
|||
| VAng-Wyb7459-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5718 |
|
Description: Leishmania Infantum Probable eukaryotic initiation factor 4A, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LinJ01.0780 Protein (aa 1-403) |
|||
| VAng-Wyb7459-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 4035.6 |
|
Description: Leishmania Infantum Probable eukaryotic initiation factor 4A, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LinJ01.0780 Protein (aa 1-403) |
|||
| VAng-Wyb7459-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2749.2 |
|
Description: Leishmania Infantum Probable eukaryotic initiation factor 4A, recombinant protein. |
|||
) Recombinant Leishmania Infantum LinJ04.0830 Protein (aa 1-438) |
|||
| VAng-Wyb7460-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Leishmania Infantum Pescadillo homolog, partial, recombinant protein. |
|||
) Recombinant Leishmania Infantum LinJ07.0210 Protein (aa 1-119) |
|||
| VAng-Wyb7461-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3556.8 |
|
Description: Leishmania Infantum Anamorsin homolog, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LinJ07.0210 Protein (aa 1-119) |
|||
| VAng-Wyb7461-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2551.2 |
|
Description: Leishmania Infantum Anamorsin homolog, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LinJ07.0210 Protein (aa 1-119) |
|||
| VAng-Wyb7461-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1759.2 |
|
Description: Leishmania Infantum Anamorsin homolog, recombinant protein. |
|||
) Recombinant Leishmania Infantum LinJ09.1490 Protein (aa 1-187) |
|||
| VAng-Wyb7462-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Leishmania Infantum Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial, partial, recombinant protein. |
|||
) Recombinant Leishmania Infantum LinJ11.0410 Protein (aa 1-808) |
|||
| VAng-Wyb7463-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Leishmania Infantum Ribosome biogenesis protein BOP1 homolog, partial, recombinant protein. |
|||
) Recombinant Leishmania Infantum LinJ11.0710 Protein (aa 1-409) |
|||
| VAng-Wyb7464-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5751.6 |
|
Description: Leishmania Infantum ATPase ASNA1 homolog, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LinJ11.0710 Protein (aa 1-409) |
|||
| VAng-Wyb7464-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 4068 |
|
Description: Leishmania Infantum ATPase ASNA1 homolog, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LinJ11.0710 Protein (aa 1-409) |
|||
| VAng-Wyb7464-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2782.8 |
|
Description: Leishmania Infantum ATPase ASNA1 homolog, recombinant protein. |
|||
) Recombinant Leishmania Infantum LinJ13.1120 Protein (aa 1-710) |
|||
| VAng-Wyb7465-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Leishmania Infantum Adenylosuccinate synthetase, partial, recombinant protein. |
|||
) Recombinant Leishmania Infantum LinJ15.0530 Protein (aa 1-158) |
|||
| VAng-Wyb7466-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3855.6 |
|
Description: Leishmania Infantum Ecotin-like protein 2, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LinJ15.0530 Protein (aa 1-158) |
|||
| VAng-Wyb7466-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2749.2 |
|
Description: Leishmania Infantum Ecotin-like protein 2, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LinJ15.0530 Protein (aa 1-158) |
|||
| VAng-Wyb7466-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1891.2 |
|
Description: Leishmania Infantum Ecotin-like protein 2, recombinant protein. |
|||
) Recombinant Leishmania Infantum LinJ15.0540 Protein (aa 1-378) |
|||
| VAng-Wyb7467-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5520 |
|
Description: Leishmania Infantum Ecotin-like protein 3, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LinJ15.0540 Protein (aa 1-378) |
|||
| VAng-Wyb7467-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3903.6 |
|
Description: Leishmania Infantum Ecotin-like protein 3, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LinJ15.0540 Protein (aa 1-378) |
|||
| VAng-Wyb7467-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2667.6 |
|
Description: Leishmania Infantum Ecotin-like protein 3, recombinant protein. |
|||
) Recombinant Leishmania Infantum LinJ18.0690 Protein (aa 1-470) |
|||
| VAng-Wyb7468-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Leishmania Infantum Probable citrate synthase, mitochondrial, partial, recombinant protein. |
|||
) Recombinant Leishmania Infantum LinJ19.0190 Protein (aa 1-412) |
|||
| VAng-Wyb7469-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Leishmania Infantum Lipoyl synthase, mitochondrial, recombinant protein. |
|||
) Recombinant Leishmania Infantum LinJ25.1190 Protein (aa 1-246) |
|||
| VAng-Wyb7470-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4514.4 |
|
Description: Leishmania Infantum Alpha-tubulin N-acetyltransferase, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LinJ25.1190 Protein (aa 1-246) |
|||
| VAng-Wyb7470-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3228 |
|
Description: Leishmania Infantum Alpha-tubulin N-acetyltransferase, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LinJ25.1190 Protein (aa 1-246) |
|||
| VAng-Wyb7470-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2188.8 |
|
Description: Leishmania Infantum Alpha-tubulin N-acetyltransferase, recombinant protein. |
|||
) Recombinant Leishmania Infantum LinJ25.1380 Protein (aa 1-705) |
|||
| VAng-Wyb7471-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Leishmania Infantum Structure-specific endonuclease subunit SLX1 homolog, partial, recombinant protein. |
|||
) Recombinant Leishmania Infantum LinJ28.1900 Protein (aa 1-225) |
|||
| VAng-Wyb7472-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4365.6 |
|
Description: Leishmania Infantum Probable methylthioribulose-1-phosphate dehydratase, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LinJ28.1900 Protein (aa 1-225) |
|||
| VAng-Wyb7472-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3112.8 |
|
Description: Leishmania Infantum Probable methylthioribulose-1-phosphate dehydratase, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LinJ28.1900 Protein (aa 1-225) |
|||
| VAng-Wyb7472-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2122.8 |
|
Description: Leishmania Infantum Probable methylthioribulose-1-phosphate dehydratase, recombinant protein. |
|||
) Recombinant Leishmania Infantum LinJ28.2880 Protein (aa 1-312) |
|||
| VAng-Wyb7473-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5025.6 |
|
Description: Leishmania Infantum Guanine nucleotide-binding protein subunit beta-like protein, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LinJ28.2880 Protein (aa 1-312) |
|||
| VAng-Wyb7473-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3556.8 |
|
Description: Leishmania Infantum Guanine nucleotide-binding protein subunit beta-like protein, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LinJ28.2880 Protein (aa 1-312) |
|||
| VAng-Wyb7473-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2436 |
|
Description: Leishmania Infantum Guanine nucleotide-binding protein subunit beta-like protein, recombinant protein. |
|||
) Recombinant Leishmania Infantum LinJ29.0880 Protein (aa 1-276) |
|||
| VAng-Wyb7474-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Leishmania Infantum Elongation factor Ts, mitochondrial, recombinant protein. |
|||
) Recombinant Leishmania Infantum LinJ32.0740 Protein (aa 1-895) |
|||
| VAng-Wyb7475-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 9843.6 |
|
Description: Leishmania Infantum Protein SEY1 homolog, partial, recombinant protein. |
|||
) Recombinant Leishmania Infantum LinJ34.0590 Protein (aa 1-834) |
|||
| VAng-Wyb7476-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Leishmania Infantum Translation factor GUF1 homolog, mitochondrial, partial, recombinant protein. |
|||
) Recombinant Leishmania Infantum LinJ35.0500 Protein (aa 2-264) |
|||
| VAng-Wyb7477-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4646.4 |
|
Description: Leishmania Infantum 40S ribosomal protein S3a-1, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LinJ35.0500 Protein (aa 2-264) |
|||
| VAng-Wyb7477-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3310.8 |
|
Description: Leishmania Infantum 40S ribosomal protein S3a-1, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LinJ35.0500 Protein (aa 2-264) |
|||
| VAng-Wyb7477-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2254.8 |
|
Description: Leishmania Infantum 40S ribosomal protein S3a-1, recombinant protein. |
|||
) Recombinant Leishmania Infantum LinJ35.0510 Protein (aa 2-264) |
|||
| VAng-Wyb7478-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4646.4 |
|
Description: Leishmania Infantum 40S ribosomal protein S3a-2, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LinJ35.0510 Protein (aa 2-264) |
|||
| VAng-Wyb7478-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3310.8 |
|
Description: Leishmania Infantum 40S ribosomal protein S3a-2, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LinJ35.0510 Protein (aa 2-264) |
|||
| VAng-Wyb7478-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2254.8 |
|
Description: Leishmania Infantum 40S ribosomal protein S3a-2, recombinant protein. |
|||
) Recombinant Leishmania Infantum LinJ36.0740 Protein (aa 1-375) |
|||
| VAng-Wyb7479-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5504.4 |
|
Description: Leishmania Infantum Methylthioribose-1-phosphate isomerase, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LinJ36.0740 Protein (aa 1-375) |
|||
| VAng-Wyb7479-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3886.8 |
|
Description: Leishmania Infantum Methylthioribose-1-phosphate isomerase, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LinJ36.0740 Protein (aa 1-375) |
|||
| VAng-Wyb7479-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2650.8 |
|
Description: Leishmania Infantum Methylthioribose-1-phosphate isomerase, recombinant protein. |
|||
) Recombinant Leishmania Infantum LinJ36.5570 Protein (aa 1-246) |
|||
| VAng-Wyb7480-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 4514.4 |
|
Description: Leishmania Infantum 40S ribosomal protein SA, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LinJ36.5570 Protein (aa 1-246) |
|||
| VAng-Wyb7480-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3228 |
|
Description: Leishmania Infantum 40S ribosomal protein SA, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LinJ36.5570 Protein (aa 1-246) |
|||
| VAng-Wyb7480-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2188.8 |
|
Description: Leishmania Infantum 40S ribosomal protein SA, recombinant protein. |
|||
) Recombinant Leishmania Infantum AdoMetDC Protein (aa 1-99) |
|||
| VAng-Wyb7443-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3408 |
|
Description: Leishmania Infantum S-adenosylmethionine decarboxylase proenzyme, recombinant protein. |
|||
|
Recombinant Leishmania Infantum AdoMetDC Protein (aa 1-99) |
|||
| VAng-Wyb7443-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 2436 |
|
Description: Leishmania Infantum S-adenosylmethionine decarboxylase proenzyme, recombinant protein. |
|||
|
Recombinant Leishmania Infantum AdoMetDC Protein (aa 1-99) |
|||
| VAng-Wyb7443-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 1677.6 |
|
Description: Leishmania Infantum S-adenosylmethionine decarboxylase proenzyme, recombinant protein. |
|||
 [His]) Recombinant Leishmania Infantum K39 Protein (aa 1-955) [His] |
|||
| VAng-Wyb7452-100g | Creative Biolabs | 100 µg | EUR 1314 |
|
Description: Leishmania Infantum kinesin-like protein, recombinant protein. |
|||
|
Recombinant Leishmania Infantum K39 Protein (aa 1-955) [His] |
|||
| VAng-Wyb7452-1mg | Creative Biolabs | 1 mg | EUR 3096 |
|
Description: Leishmania Infantum kinesin-like protein, recombinant protein. |
|||
|
Recombinant Leishmania Infantum K39 Protein (aa 1-955) [His] |
|||
| VAng-Wyb7452-500g | Creative Biolabs | 500 µg | EUR 2205.6 |
|
Description: Leishmania Infantum kinesin-like protein, recombinant protein. |
|||
) Recombinant Leishmania infantum Anamorsin homolog (LinJ07.0210, LinJ_07_0390) |
|||
| MBS1001330-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | EUR 1040 |
|
Recombinant Leishmania infantum Anamorsin homolog (LinJ07.0210, LinJ_07_0390) |
|||
| MBS1001330-002mgEColi | MyBiosource | 0.02mg(E-Coli) | EUR 620 |
|
Recombinant Leishmania infantum Anamorsin homolog (LinJ07.0210, LinJ_07_0390) |
|||
| MBS1001330-002mgYeast | MyBiosource | 0.02mg(Yeast) | EUR 795 |
|
Recombinant Leishmania infantum Anamorsin homolog (LinJ07.0210, LinJ_07_0390) |
|||
| MBS1001330-01mgEColi | MyBiosource | 0.1mg(E-Coli) | EUR 720 |
|
Recombinant Leishmania infantum Anamorsin homolog (LinJ07.0210, LinJ_07_0390) |
|||
| MBS1001330-01mgYeast | MyBiosource | 0.1mg(Yeast) | EUR 930 |
) Recombinant Leishmania Infantum LIPO-A Protein (aa 1-323) |
|||
| VAng-Wyb7481-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 5108.4 |
|
Description: Leishmania Infantum 60S acidic ribosomal protein P0, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LIPO-A Protein (aa 1-323) |
|||
| VAng-Wyb7481-500gEcoli | Creative Biolabs | 500 µg (E. coli) | EUR 3606 |
|
Description: Leishmania Infantum 60S acidic ribosomal protein P0, recombinant protein. |
|||
|
Recombinant Leishmania Infantum LIPO-A Protein (aa 1-323) |
|||
| VAng-Wyb7481-50gEcoli | Creative Biolabs | 50 µg (E. coli) | EUR 2469.6 |
|
Description: Leishmania Infantum 60S acidic ribosomal protein P0, recombinant protein. |
|||
) Recombinant Leishmania Infantum HSP83-1 Protein (aa 1-701) |
|||
| VAng-Wyb7448-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Leishmania Infantum Heat shock protein 83-1, partial, recombinant protein. |
|||
) Recombinant Leishmania Infantum KMP-11B Protein (aa 1-92) |
|||
| VAng-Wyb7453-1mgEcoli | Creative Biolabs | 1 mg (E. coli) | EUR 3342 |
|
Description: Leishmania Infantum Kinetoplastid membrane protein 11B, recombinant protein. |
|||
IMPORTANCE Twelve million people worldwide endure from leishmaniasis, resulting in larger than thirty thousand deaths yearly. The sickness has quite a lot of variants that differ of their indicators. The mucocutaneous kind, which ends up in disintegration of the nasal septum, lips, and palate, is predominantly introduced on by Leishmania parasites carrying Leishmania RNA virus 1 (LRV1).